Lupus Anticoagulant

Lupus anticoagulant (LA) is a type of antibody produced by the immune system. Contrary to its name, lupus anticoagulant may not have a direct relationship with lupus disease. This antibody attacks proteins in the body that normally prevent blood clotting, resulting in an increased tendency for blood to clot.

In blood clotting tests (coagulation tests), lupus anticoagulant can lead to abnormal results. In such cases, the blood clotting process can either take longer than normal or clot faster than usual. Lupus anticoagulant can predispose blood to abnormal clotting before an actual clot is formed, increasing the risk of venous or arterial thrombosis.

Individuals with the presence of this antibody may experience clotting issues. However, the existence of lupus anticoagulant in a person does not necessarily imply the formation of a clot, nor does it signify lupus disease itself. It is crucial to assess the clotting risk and take appropriate measures for individuals with lupus anticoagulant present. With guidance from a specialist and careful evaluation of test results, precautions can be taken against this condition.

Lupus Anticoagulant Test:

The lupus anticoagulant test is conducted to measure the presence of antibodies produced by the immune system. While these antibodies usually regulate blood clotting, those termed lupus anticoagulant can cause abnormal clotting. This test is used to identify clotting disorders and conditions like antiphospholipid syndrome.

When Is the Lupus Anticoagulant Test Ordered?

1. History of Thrombosis:

For individuals who have previously experienced deep vein thrombosis (DVT), pulmonary embolism (PE), or arterial thrombosis (such as stroke).

2. Recurrent Pregnancy Losses:

In women experiencing recurrent miscarriages or issues during pregnancy.

3. Suspected Antiphospholipid Syndrome:

A condition that arises with the presence of antibodies like lupus anticoagulant. It increases the risk of thrombosis and can be associated with recurrent miscarriages.

4. Dialysis Patients:

For individuals with chronic kidney disease or undergoing dialysis treatment to assess vascular thrombosis risk.

5. Diagnosis of Immunological Disorders:

In the diagnosis or monitoring of autoimmune diseases like systemic lupus erythematosus (SLE), especially in patients showing symptoms of antiphospholipid syndrome.

This test is requested by doctors considering a person's clinical symptoms and medical history, aiding in the identification of clotting disorders like antiphospholipid syndrome.